Vor Biopharma (VOR) stock gains as J.P. Morgan issues an Overweight recommendation for the company, citing a blockbuster ...

Discover Vor BiopharmaVor Biopharma Inc.'s potential with telitacicept amid funding challenges and market risks. Click for ...

EyePoint is headquartered in Watertown, Massachusetts, with a commercial manufacturing facility in Northbridge, Massachusetts. Vorolanib is licensed to EyePoint exclusively by Equinox Sciences, a ...

Partnering Platform Now Open for RegistrationSAN FRANCISCO--(BUSINESS WIRE)--#biotechshowcase--Biotech Showcase™ returns to ...

PRISM BioLab is collaborating on new PPI targets with global and Japanese pharmaceutical companies. PepMetics ® targeting CBP/beta-catenin PPIs licensed to Eisai Co., Ltd. and Ohara Pharmaceutical Co.

Vor Bio (NASDAQ:VOR) announced on Monday that it has entered into a securities purchase agreement to sell 13.87M shares of its common stock at a price of $10.81 per share in a private placement. The ...

LUND, SE / / December 18, 2025 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and first-in-class ...

Biotech’s slump may finally be over in 2026. In interviews with BioSpace, Zymeworks’ CEO Ken Galbraith and Zai Lab’s ...

SkyDeck and Bakar Labs to Highlight 24 Emerging Companies From Across Campus, Illustrating Berkeley’s ‘Open Bazaar’ Model for Scientific and Entrepreneurial Innovation BERKELEY, CA / ACCESS Newswire / ...

Ability Biotherapeutics, a biotechnology company advancing logic-gated antibody therapies for cancer and autoimmune diseases, ...

Secondary offerings from biotechs Immunovant, Kymera Therapeutics, and Wave Life Sciences prompted some huge insider buying recently.

Pedophile Jeffrey Epstein ensured that a Google search for his name would return several websites about his donations to science ...